TARO News and Press, Taro Pharmaceutical Industries Ltd. From 01/25/24

2024-01-25 17:14:51 ET More on Taro Pharmaceutical Taro Pharmaceutical Industries Ltd. Is An Overlooked Opportunity Taro Pharmaceutical Q3 2024 Earnings Preview Sun Pharma to take Taro private for $43 per share Seeking Alpha’s Quant Rating on Taro Phar...

Koss Corporation (KOSS) is expected to report for Q2 2024 Waterstone Financial Inc. (WSBF) is expected to report for Q4 2023 Silver Bull Resources Inc (SVBL) is expected to report for quarter end 2023-10-31 Xcel Energy Inc. (XEL) is expected to report $0.85 for Q4 2023 Sodexo ADR ...

2024-01-24 17:35:58 ET More on Taro Pharmaceutical Taro Pharmaceutical Industries Ltd. Is An Overlooked Opportunity Sun Pharma to take Taro private for $43 per share Seeking Alpha’s Quant Rating on Taro Pharmaceutical Historical earnings data for Taro ...

Swatch Group AG ADR (SWGAY) is expected to report for Q4 2023 GATX Corporation (GATX) is expected to report $1.56 for Q4 2023 C&F Financial Corporation (CFFI) is expected to report for Q4 2023 Verizon Communications Inc. (VZ) is expected to report $1.07 for Q4 2023 Renasant Co...

2024-01-22 12:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the third quarter ended December 31, 2023, after the close of market on Thursday, January 25, 2024. The release will be accessible on Taro’s website at www.taro.com ....

2024-01-17 17:07:13 ET More on Taro Pharmaceutical Taro Pharmaceutical Industries Ltd. Is An Overlooked Opportunity Taro Pharmaceutical Q2 2024 Earnings Preview Seeking Alpha’s Quant Rating on Taro Pharmaceutical Historical earnings data for Taro Pharm...

2024-01-11 20:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-12 06:07:01 ET Summary Taro Pharmaceutical Industries is a hidden treasure in the pharmaceutical industry, with a Strong Buy Quant Rating and positive financials. The company has been overshadowed by Teva Pharmaceutical Industries but has potential for growth in its niche....

2023-10-26 17:07:56 ET Taro Pharmaceutical press release ( NYSE: TARO ): Q2 GAAP EPS of $0.23. Revenue of $148.2M (+13.6% Y/Y). Research and development (R&D) expenses of $14.3 million increased $2.8 million, principally the result of increased clinical studies. ...